4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amineMyocardial InfarctionInfarctionElectrocardiographyCerebral InfarctionAngioplasty, Balloon, CoronaryThrombolytic TherapyTime FactorsCoronary AngiographyAnterior Wall Myocardial InfarctionMyocardial ReperfusionTreatment OutcomeRisk FactorsVentricular RemodelingProspective StudiesStreptokinaseCreatine KinaseMyocardiumCoronary Care UnitsVentricular Function, LeftFibrinolytic AgentsCoronary DiseasePrognosisFollow-Up StudiesAngina PectorisPlatelet Aggregation InhibitorsPredictive Value of TestsAngina, UnstableEchocardiographyStentsPercutaneous Coronary InterventionMyocardial RevascularizationCoronary ThrombosisMyocardial IschemiaStroke VolumeRecurrenceVentricular Dysfunction, LeftCoronary VesselsShock, CardiogenicRisk AssessmentInferior Wall Myocardial InfarctionCoronary Artery DiseaseRetrospective StudiesHospital MortalityAcute DiseaseCoronary CirculationHeartChest PainHeart FailureBiological MarkersCoronary Artery BypassProportional Hazards ModelsRegistriesIncidenceStrokeAspirinHeart VentriclesArrhythmias, CardiacCardiac CatheterizationAcute Coronary SyndromeCohort StudiesSurvival AnalysisTissue Plasminogen ActivatorHeart Rupture, Post-InfarctionCase-Control StudiesMultivariate AnalysisHemodynamicsHospitalizationHemorrhageDrug-Eluting StentsClinical Enzyme TestsTroponin TRiskVentricular Function, RightVentricular Dysfunction, Right